Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
With
ZonMw: The Netherlands Organisation for Health Research and Development
Evidence for optimal duration and necessary ingredients of early and sustained specialized treatment from first episode psychosis till the end of the initial phase schizophrenia is still insufficient. Randomized trials with a treatment duration of six months to two years with favorable symptomatic and psychosocial results disappeared at five year follow-up. Other studies suggest that specialized treatment should last 5 years in order to be able to prevent instead of only delaying clinical and psychosocial deteriorating.
In this study we examine both the symptomatic (relapse) and psychosocial outcome of a three armed five year randomized trial in the initial phase of schizophrenia.
Age
15–28
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients were eligible for the study if they: 1) met DSM-IV-Revised criteria for schizophrenia or related disorders, 2) were suffering from a first psychotic episode and 3) were living in contact with parent(s) or other relatives.
You may not be if
Patients with drug-related psychoses were not included.
Clareo Health | Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
